| NCT ID | NCT06975657 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Formerly Incarcerated Adults |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-12 |
| Primary Completion | 2027-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-01-12 with a primary completion date of 2027-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if a mindfulness skills training program has mental health benefits for people returning to the community following incarceration. The main questions it aims to answer are: * Does mindfulness skills training improve symptoms of anxiety and depression? * Do participants find this mindfulness program to be acceptable and feasible to participate in? Researchers will compare outcomes for participants in the mindfulness training program to those in a waitlist control group who will receive the mindfulness program after the end of the study. Participants will: * Complete an initial intake visit, consisting of an interview and questionnaires * Randomly be assigned to a mindfulness group or a waitlist control group * Participate in weekly mindfulness classes for 6 weeks (mindfulness group only) * Complete a set of questionnaires after the conclusion of the mindfulness classes * Complete a set of questionnaires and an interview 2 months after the conclusion of the mindfulness classes
Eligibility Criteria
Inclusion Criteria: * Age 18 or older * Formerly incarcerated in a local jail, state or federal prison * Can read, speak and understand English * Able to provide informed consent Exclusion Criteria: * Suicidal ideation with some intent to act or with a specific plan and intent * Active psychosis * Daily or nearly daily use (over the past 3 months) of the following substances: cocaine, amphetamines, inhalants, sedatives or sleeping pills, hallucinogens, or opioids
Contact & Investigator
Dan Grupe, PhD
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT06975657 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Formerly Incarcerated Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06975657 currently recruiting?
Yes, NCT06975657 is actively recruiting participants. Contact the research team at mindful-reentry@chm.wisc.edu for enrollment information.
Where is the NCT06975657 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT06975657 clinical trial?
NCT06975657 is sponsored by University of Wisconsin, Madison. The principal investigator is Dan Grupe, PhD at University of Wisconsin, Madison. The trial plans to enroll 60 participants.